Clinical Trial

Efficacy and Safety Study of HS-10542 for IgA Nephropathy

Name: Efficacy and Safety Study of HS-10542 for IgA Nephropathy — clinical trial record (NCT07474636)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: HS-10542

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a multicenter, randomized, double-blind, parallel, placebo-controlled study and is being conducted to evaluate the efficacy and safety of HS-10542 capsules for primary IgA nephropathy.

Trial Details

NCT Number	NCT07474636
Lead Sponsor	Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions	IgAN, Immunoglobulin A Nephropathy (IgAN), Glomerular Disease
Enrollment	90 participants
Start Date	2026-03-17
Primary Completion	2027-12-10 (estimated)
Study Completion	2028-01-30 (estimated)
Updated on ClinicalTrials.gov	2026-03-16